# Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

> **NCT05091385** · — · COMPLETED · sponsor: **Medical University of Lodz** · enrollment: 106 (actual)

## Conditions studied

- Asthma; Eosinophilic

## Interventions

- **BIOLOGICAL:** Mepolizumab given SC 100mg every 4 weeks between Dec 2017 and Dec 2019

## Key facts

- **NCT ID:** NCT05091385
- **Lead sponsor:** Medical University of Lodz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-08-06
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05091385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05091385, "Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05091385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*